文献速递生殖医学

两名多发性硬化不孕女性安全成功应用卵母细胞体外成熟技术

Safe and successful use of oocyte in-vitro maturation in two infertile women with multiple sclerosis.
PubMed 文献 · Reprod Biomed Online · 2020-02-21

报告两名多发性硬化不孕女性,因担心卵巢刺激加重疾病而采用卵母细胞体外成熟方案避免使用促排卵药物,均足月分娩健康婴儿,治疗及妊娠期间多发性硬化均未复发。作者认为体外成熟可作为合适多发性硬化女性的替代选择。

要点

  • 两名多发性硬化不孕女性采用卵母细胞体外成熟方案以避免卵巢刺激。
  • 两人均足月分娩健康婴儿,治疗及妊娠期间多发性硬化未复发。
  • 作者认为体外成熟可作为合适多发性硬化女性的替代选择。

核心结论

  • 卵母细胞体外成熟可作为合适多发性硬化女性的替代选择。
  • 据作者所知,这是文献中首次描述多发性硬化母亲经体外成熟后分娩的婴儿。

研究设计与样本

  • 报告两家大型三级大学医院的两名多发性硬化不孕女性,因担心卵巢刺激加重多发性硬化而转诊至不孕门诊并接受体外成熟方案。

主要发现

  • 两名患者均足月分娩健康婴儿。
  • 两名患者在治疗期间及妊娠期间均未出现多发性硬化复发。

临床怎么用

  • 作者认为,卵母细胞体外成熟可作为合适多发性硬化女性的替代选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is evidence to support an impact of ovarian stimulation with gonadotrophin-releasing hormone analogues on the progression or recurrence of multiple sclerosis. In addition, there is no universally acknowledged approach toward ovarian stimulation in patients with multiple sclerosis. This report describes two patients at a large tertiary university hospital who underwent an in-vitro maturation protocol in order to avoid a risk of exacerbating their multiple sclerosis by ovarian stimulation. Both patients were referred to the infertility clinic because of the concern of exacerbation of multiple sclerosis during or after ovarian stimulation treatment. The patients underwent the in-vitro maturation protocol to avoid ovarian stimulating agents. Both patients gave birth to healthy babies at term. They did not suffer any relapses of multiple sclerosis during their treatment or during pregnancy. Exacerbation of disease related to ovarian stimulation encourages the search for a safer approach to these patients. To the authors' knowledge, these are the first babies described in the literature who were born after in-vitro maturation to mothers suffering from multiple sclerosis. In-vitro maturation can thus be recommended as an alternative in suitable women with multiple sclerosis.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Gulekli B, Kovali Sezer M, Gungor SS, et al. Safe and successful use of oocyte in-vitro maturation in two infertile women with multiple sclerosis. Reprod Biomed Online. 2020. PMID: 32536541. doi:10.1016/j.rbmo.2020.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。